Related Experiment Videos
[Molecular biology in the diagnosis of cardiovascular diseases]
1Institutt for medisinsk genetikk Universitetet i Oslo.
Insights
Genetic factors significantly influence coronary heart disease (CHD) risk. Gene interactions and lifestyle factors, alongside specific biomarkers like Lp(a), fibrinogen, and homocysteine, are crucial for diagnosing and managing CHD.
Area of Science:
- Genetics and Cardiovascular Disease Research
- Molecular Biology and Disease Mechanisms
Context:
- Coronary heart disease (CHD) risk is influenced by multiple genetic loci.
- Both rare mutations and common polymorphisms in genes like APOB, APOAI, LPA, LDLR, APOE, and CETP contribute to CHD risk.
- Gene-gene interactions, such as between LDLR and APOE, play a role in disease susceptibility.
Purpose:
- To identify and summarize the genetic factors influencing coronary heart disease (CHD).
- To highlight the clinical significance of genetic variations and their interaction with environmental factors.
- To emphasize the importance of specific biomarkers and genetic analyses in CHD diagnosis and management.
Summary:
- Genetic loci including APOB, APOAI, LPA, LDLR, APOE, and CETP are associated with coronary heart disease (CHD) risk factors.
- While rare mutations have a major impact, common gene polymorphisms and gene-gene interactions (e.g., LDLR-APOE) contribute moderately.
- Biomarkers such as Lp(a) lipoprotein, fibrinogen, and homocysteine, alongside DNA analysis for conditions like familial hypercholesterolemia, are increasingly important for CHD diagnosis.
Impact:
- Genetic insights can refine CHD risk assessment and personalized treatment strategies.
- Understanding gene-environment interactions is key to comprehensive cardiovascular disease prevention.
- The growing role of mutation analysis in clinical practice for diagnosing genetic lipid disorders and predicting CHD risk.
Abstract:
Genes shown to affect risk factors or protective factors with respect to coronary heart disease (CHD) have been identified at the APOB, APOAI, LPA, LDLR, APOE and CETP loci. Rare mutations (e.g., in the LDLR and APOE genes) may have a major effect, whereas genes belonging to normal polymorphism have only a moderate effect. Even genes with only a slight effect can be clinically important in combination with other genes or life-style factors. There is gene to gene interaction between LDLR and APOE genes. Important risk factors determined by genes as well as by environmental factors are homocystein and fibrinogen. In addition to traditional lipid and apoprotein measurements, the levels of Lp(a) lipoprotein, fibrinogen and homocystein should be examined in connection with diagnosing CHD cases. DNA analyses are appropriate when familial hypercholesterolemia is suspected, and it is likely that the importance of mutation analyses will increase significantly in the near future.